Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |